Product
Double-Stranded RNA
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Double-Blind, Placebo-Controlled Multicentre Clinical Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure ProphylaxisStatus: Completed, Estimated PCD: 2022-11-22